Acute Stroke as First Manifestation of Cerebral Aspergillosis

J Stroke Cerebrovasc Dis. 2018 Nov;27(11):3289-3293. doi: 10.1016/j.jstrokecerebrovasdis.2018.07.031. Epub 2018 Aug 29.

Abstract

Objectives: To describe the neurological manifestations of invasive aspergillosis presenting with a focal neurological deficit compatible with an acute stroke.

Materials and methods: Retrospective analysis of a clinical series of patients between 2011 and 2017 with invasive aspergillosis and neurological symptoms compatible with an acute brain stroke. Clinical and epidemiological data, microbiological results, radiological findings, treatment, and course were recorded.

Results: Five patients were selected with a mean age of 55.4years. All patients were immunosuppressed. In 4, systemic infection was unknown. In every case, neurology on call was alerted because of acute focal neurological symptoms. None of the patients received revascularization procedures. Galactomannan antigen was positive in all of the patients and culture was positive in 3. Mortality was 100% despite specific antifungal treatment.

Conclusions: Acute stroke can be the first manifestation of disseminated aspergillosis. This form of presentation was frequent in our series and should be suspected in immunocompromised patients with acute neurological deficits.

Keywords: Neuroaspergillosis; acute stroke; antifungal therapy; invasive aspergillosis.

MeSH terms

  • Antifungal Agents / therapeutic use
  • Autopsy
  • Female
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neuroaspergillosis / diagnosis
  • Neuroaspergillosis / immunology
  • Neuroaspergillosis / microbiology*
  • Neuroaspergillosis / mortality
  • Opportunistic Infections / diagnosis
  • Opportunistic Infections / immunology
  • Opportunistic Infections / microbiology*
  • Opportunistic Infections / mortality
  • Retrospective Studies
  • Risk Factors
  • Spain
  • Stroke / diagnostic imaging
  • Stroke / immunology
  • Stroke / microbiology*
  • Stroke / mortality
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Immunosuppressive Agents